Cite
HARVARD Citation
Plummer, R. et al. (2022). A phase 1b study evaluating the safety and preliminary efficacy of berzosertib in combination with gemcitabine in patients with advanced non-small cell lung cancer. Lung cancer. pp. 19-26. [Online].